499424574	499424574	CD	B-NP	O
|	|	NN	I-NP	O
CHMC	CHMC	NN	I-NP	O
|	|	NN	I-NP	O
42778004	42778004	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7319798	7319798	CD	B-NP	O
|	|	CC	I-NP	O
11/25/2005	11/25/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2005	10/6/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
LEGGET	LEGGET	NNP	B-NP	O
,	,	,	O	O
BASIL	BASIL	NNP	B-NP	O
MALCOM	MALCOM	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Admitted	Admit	VBD	B-VP	O
10/18/05	10/18/05	CD	B-NP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Alan	Alan	NNP	I-NP	O
Smaniotto	Smaniotto	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Poor	Poor	NNP	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	FW	I-NP	O
and	and	CC	O	O
failure	failure	NN	B-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
This	This	DT	B-NP	O
77-year-old	77-year-old	JJ	I-NP	O
female	female	JJ	I-NP	O
first	first	JJ	I-NP	O
noted	note	VBN	I-NP	O
dysphagia	dysphagia	NN	I-NP	O
beginning	begin	VBG	B-VP	O
in	in	IN	B-PP	O
approximately	approximately	RB	B-NP	O
October	October	NNP	I-NP	O
2005	2005	CD	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
then	then	RB	B-NP	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
persisted	persist	VBN	I-VP	O
and	and	CC	I-VP	O
worsened	worsen	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
endoscopy	endoscopy	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
upper	upper	JJ	I-NP	O
endoscopy	endoscopy	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Arma	Arma	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
Health	Health	NNP	I-NP	O
The	The	DT	B-NP	O
EGD	EGD	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
Ms.	Ms.	NNP	B-NP	O
Hinrichsen	Hinrichsen	NNP	I-NP	O
had	have	VBD	B-VP	O
Barrett	Barrett	NNP	B-NP	O
's	's	POS	B-NP	O
esophagus	esophagus	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
nodule	nodule	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
esophagus	esophagus	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nodule	nodule	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
poorly	poorly	RB	B-NP	O
differentiated	differentiate	VBN	I-NP	O
invasive	invasive	JJ	I-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
at	at	IN	B-PP	O
35	35	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
rising	rise	VBG	I-VP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
Barrett	Barrett	NNP	B-NP	O
's	's	POS	B-NP	O
esophagitis	esophagitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
myopathy	myopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
LVEF	LVEF	NN	I-NP	B-protein
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
CAD	CAD	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
bypass	bypass	NN	B-NP	O
graft	graft	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
biventricular	biventricular	JJ	I-NP	O
ICD	ICD	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2004	2004	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
endoscopy	endoscopy	NN	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
EUS	EUS	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
intramural	intramural	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
esophagus	esophagus	NN	I-NP	O
measuring	measure	VBG	B-VP	O
2	2	CD	B-NP	O
cm	cm	NN	I-NP	O
in	in	IN	B-PP	O
diameter	diameter	NN	B-NP	O
invading	invade	VBG	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
muscularis	muscularis	NN	I-NP	O
propria	propria	NN	I-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
staged	stag	VBN	I-VP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
T3	T3	NN	B-NP	B-DNA
,	,	,	O	O
N0	N0	NN	B-NP	B-protein
,	,	,	O	O
MX	MX	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
tumor	tumor	NN	B-NP	O
by	by	IN	B-PP	O
EUS	EUS	NNS	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
at	at	IN	B-PP	O
Toards	Toards	NNP	B-NP	O
Health	Health	NNP	I-NP	O
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
July	July	NNP	I-NP	O
by	by	IN	B-PP	O
both	both	DT	B-NP	O
Dr.	Dr.	NNP	B-NP	O
Tyrell	Tyrell	NNP	I-NP	O
Aningalan	Aningalan	NNP	I-NP	O
from	from	IN	B-PP	O
Medial	Medial	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Wahlen	Wahlen	NNP	I-NP	O
from	from	IN	B-PP	O
Radiation	Radiation	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
reasonable	reasonable	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
chemoradiation	chemoradiation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
began	begin	VBD	B-VP	O
her	her	PRP$	B-NP	O
chemoradiation	chemoradiation	NN	I-NP	O
and	and	CC	I-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
,	,	,	O	O
chemotherapy	chemotherapy	NN	B-NP	O
including	include	VBG	B-PP	O
Taxol	Taxol	NN	B-NP	O
and	and	CC	I-NP	O
cisplatin	cisplatin	NN	I-NP	O
.	.	.	O	O

Approximately	Approximately	RB	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
unfortunately	unfortunately	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
reports	report	VBZ	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	I-VP	O
dysphagia	dysphagia	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
having	have	VBG	I-VP	O
trouble	trouble	NN	B-NP	O
swallowing	swallow	VBG	B-VP	O
liquids	liquid	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
routine	routine	JJ	I-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
and	and	CC	I-NP	O
difficulty	difficulty	NN	I-NP	O
getting	get	VBG	B-VP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
radiation	radiation	NN	I-NP	O
table	table	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dehydrated	dehydrate	VBN	I-VP	O
and	and	CC	O	O
weak	weak	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
or	or	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
very	very	RB	B-NP	O
poor	poor	JJ	I-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
notes	note	VBZ	B-VP	O
some	some	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
vessel	vessel	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
biventricular	biventricular	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
placed	place	VBN	B-VP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Diverticulosis	Diverticulosis	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
gallbladder	gallbladder	NN	I-NP	O
removal	removal	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

A-fib	A-fib	NN	B-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Esophageal	Esophageal	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
chemo	chemo	NN	I-NP	O
on	on	IN	B-PP	O
XRT	XRT	NN	B-NP	B-DNA
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Codeine	Codeine	NN	B-NP	O
causes	cause	VBZ	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
and	and	CC	I-NP	O
Demerol	Demerol	NN	I-NP	O
caused	cause	VBD	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
,	,	,	O	O
amoxicillin/clavulanic	amoxicillin/clavulanic	JJ	B-NP	O
acid	acid	NN	I-NP	O
caused	cause	VBD	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
,	,	,	O	O
azelastine	azelastine	NN	B-NP	O
causes	cause	VBZ	B-VP	O
stinging	stinging	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
amiodarone	amiodarone	NN	B-NP	O
causes	cause	VBZ	B-VP	O
cold	cold	JJ	B-NP	O
sweats	sweat	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
Lopressor	Lopressor	NNP	B-NP	O
50	50	CD	I-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Prevacid	Prevacid	NNP	B-NP	O
30	30	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Zocor	Zocor	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
and	and	CC	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
homemaker	homemaker	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
occasionally	occasionally	RB	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
father	father	NN	I-NP	O
with	with	IN	B-PP	O
melanoma	melanoma	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
mother	mother	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
59	59	CD	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NN	B-NP	O
OF	OF	IN	B-PP	O
SYSTEM	SYSTEM	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
joint	joint	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
VITAL	VITAL	NN	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
temp	temp	NN	I-NP	O
was	be	VBD	B-VP	O
97.4	97.4	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
86	86	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
87/56	87/56	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
alert	alert	JJ	I-NP	O
,	,	,	I-NP	O
oriented	oriented	JJ	I-NP	O
,	,	,	I-NP	O
cooperative	cooperative	JJ	I-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
resting	rest	VBG	I-VP	O
comfortably	comfortably	RB	B-ADVP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
were	be	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
motions	motion	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
or	or	CC	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
7	7	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
irregularly	irregularly	RB	B-ADJP	O
regular	regular	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
loudest	loud	JJS	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
bruising	bruising	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
37	37	CD	B-NP	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
and	and	CC	I-NP	O
CBC	CBC	NN	I-NP	B-protein
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
2.7	2.7	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
albumin	albumin	NN	I-NP	O
was	be	VBD	B-VP	O
3.7	3.7	CD	B-NP	O
,	,	,	O	O
mag	mag	NN	B-NP	O
1.5	1.5	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
A-fib	A-fib	NN	B-NP	B-protein
,	,	,	O	O
A-flutter	A-flutter	JJ	B-ADJP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
paced	paced	JJ	I-NP	O
beats	beat	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
pacer	pacer	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
77-year-old	77-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	O	O
esophageal	esophageal	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
having	have	VBG	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
are	be	VBP	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
dehydration	dehydration	NN	B-NP	O
.	.	.	O	O

Unlikely	Unlikely	RB	B-ADVP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
cause	cause	NN	I-NP	O
given	give	VBN	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitation	palpitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
obviously	obviously	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
p.o.	p.o.	FW	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lightheadedness	Lightheadedness	NN	B-NP	O
:	:	:	O	O
Poor	Poor	FW	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	I-NP	O
dehydration	dehydration	NN	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
regarding	regard	VBG	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
stent	stent	NN	I-NP	O
in	in	IN	B-PP	O
esophagus	esophagus	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
gentle	gentle	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
overnight	overnight	NN	I-NP	O
,	,	,	O	O
measure	measure	NN	B-NP	O
orthostatics	orthostatic	NNS	I-NP	O
,	,	,	O	O
holding	hold	VBG	B-VP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
checking	check	VBG	B-VP	O
BNP	BNP	NN	B-NP	B-protein
and	and	CC	I-NP	O
monitor	monitor	NN	I-NP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
for	for	IN	B-PP	O
arrhythmia	arrhythmia	NN	B-NP	O
,	,	,	O	O
continue	continue	JJ	B-NP	O
digoxin	digoxin	NN	I-NP	O
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
continue	continue	VB	B-VP	O
Imdur	Imdur	NNP	B-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
Lasix	Lasix	NNP	B-NP	O
while	while	IN	B-SBAR	O
hydrating	hydrate	VBG	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Esophageal	Esophageal	NNP	B-NP	O
Cancer	Cancer	NNP	I-NP	O
:	:	:	O	O
Got	Got	NNP	B-NP	O
XRT	XRT	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
XRT	XRT	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Nausea	Nausea	NNP	B-NP	O
:	:	:	O	O
Rx	Rx	NN	B-NP	B-protein
for	for	IN	B-PP	O
Zofran	Zofran	NN	B-NP	O
and	and	CC	O	O
replete	replete	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
:	:	:	O	O
Continue	Continue	NNP	B-NP	O
Synthroid	Synthroid	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GERD	GERD	NNP	B-NP	O
:	:	:	O	O
Continue	Continue	NNP	B-NP	O
Prevacid	Prevacid	NNP	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

A-fib	A-fib	NN	B-NP	O
:	:	:	O	O
Continue	Continue	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
:	:	:	O	O
Continue	Continue	NNP	B-NP	O
Zocor	Zocor	NNP	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Replete	Replete	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
multivitamin	multivitamin	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
Subcutaneous	Subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	I-NP	O
Prevacid	Prevacid	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lightheadedness	Lightheadedness	NN	B-NP	O
:	:	:	O	O
It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
dehydration	dehydration	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
hydration	hydration	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
evaluated	evaluate	VBD	B-VP	O
her	her	PRP	B-NP	O
and	and	CC	O	O
suggested	suggest	VBD	B-VP	O
high	high	JJ	B-NP	O
calorie	calorie	NN	I-NP	O
supplements	supplement	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
nauseated	nauseate	VBN	I-VP	O
and	and	CC	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
good	good	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
GI	GI	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
regarding	regard	VBG	B-PP	O
possible	possible	JJ	B-NP	O
stenting	stenting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
esophagus	esophagus	NN	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
intra-esophageal	intra-esophageal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
potentially	potentially	RB	I-VP	O
be	be	VB	I-VP	O
causing	cause	VBG	I-VP	O
this	this	DT	B-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
ordered	order	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
barium	barium	NN	I-NP	O
swallow	swallow	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
barium	barium	NN	I-NP	O
swallow	swallow	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
strict	strict	JJ	I-NP	O
stenotic	stenotic	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
esophagus	esophagus	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
allowed	allow	VBN	I-VP	O
any	any	DT	B-NP	O
food	food	NN	I-NP	O
to	to	TO	B-VP	O
pass	pass	VB	I-VP	O
through	through	IN	B-ADVP	O
.	.	.	O	O

An	An	DT	B-NP	O
EGD	EGD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
food	food	NN	I-NP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
tight	tight	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
passed	pass	VBN	I-VP	O
.	.	.	O	O

Based	Base	VBN	B-VP	O
upon	upon	IN	B-PP	O
this	this	DT	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
G-tube	G-tube	NNP	I-NP	O
.	.	.	O	O

Interventional	Interventional	JJ	B-NP	O
radiology	radiology	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
a	a	DT	B-NP	O
G-tube	G-tube	NN	I-NP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

Tube	Tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
were	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
them	them	PRP	B-NP	O
well	well	RB	B-ADVP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
at	at	IN	B-PP	O
goal	goal	NN	B-NP	O
of	of	IN	B-PP	O
360	360	CD	B-NP	O
cc	cc	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
scoop	scoop	NN	I-NP	O
of	of	IN	B-PP	O
promod	promod	NN	B-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

TIA/CVA	TIA/CVA	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
5/24/05	5/24/05	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-VP	O
upon	upon	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
STAT	STAT	NN	I-NP	B-protein
CT	CT	NN	I-NP	O
and	and	CC	I-NP	O
CTA	CTA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
regained	regain	VBD	B-VP	O
all	all	DT	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
CTA	CTA	NN	I-NP	B-protein
did	do	VBD	B-VP	O
note	note	VB	I-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
friable	friable	JJ	I-NP	O
clot	clot	NN	I-NP	O
within	within	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-VP	O
upon	upon	IN	B-PP	O
her	her	PRP$	B-NP	O
high	high	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
operative	operative	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
stent	stent	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
TIA	TIA	NN	I-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
8/16/05	8/16/05	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
left-sided	left-sided	JJ	I-NP	O
facial	facial	JJ	I-NP	O
droop	droop	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
left-sided	left-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
STAT	STAT	NN	I-NP	B-protein
CT	CT	NN	I-NP	O
,	,	,	O	O
CTA	CTA	NN	B-NP	B-protein
once	once	RB	B-ADVP	O
again	again	RB	I-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
clot	clot	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
moved	move	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
MCA	MCA	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
dissolved	dissolve	VBN	I-VP	O
somewhat	somewhat	RB	B-ADVP	O
.	.	.	O	O

Based	Base	VBN	B-VP	O
upon	upon	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
good	good	JJ	B-NP	O
recovery	recovery	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
sort	sort	NN	I-NP	O
of	of	IN	B-PP	O
intervention	intervention	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
give	give	VB	I-VP	O
her	her	PRP	B-NP	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
as	as	IN	B-PP	O
bridging	bridge	VBG	B-VP	O
over	over	RP	B-PRT	O
while	while	IN	B-SBAR	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
became	become	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	B-cell_type
drip	drip	NN	I-NP	I-cell_type
until	until	IN	B-PP	I-cell_type
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
life	life	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Esophageal	Esophageal	NNP	B-NP	O
Cancer	Cancer	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
XRT	XRT	NN	B-NP	B-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
time	time	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Conversations	Conversation	NNS	B-NP	O
between	between	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Depaoli	Depaoli	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Serl	Serl	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
were	be	VBD	B-VP	O
had	have	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
a	a	DT	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
candidate	candidate	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
poor	poor	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
other	other	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
XRT	XRT	NN	B-NP	B-DNA
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
Renal	Renal	JJ	I-NP	O
Failure	Failure	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
creatinine	creatinine	NN	I-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
dehydration	dehydration	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
defect	defect	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
continued	continue	VBD	B-VP	O
trending	trend	VBG	I-VP	O
down	down	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
0.9	0.9	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
for	for	IN	B-PP	O
arrhythmia	arrhythmia	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
biventricular	biventricular	JJ	B-NP	O
pacer	pacer	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
lead	lead	NN	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
place	place	NN	B-NP	O
causing	cause	VBG	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
complex	complex	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
alarms	alarm	NNS	I-NP	O
for	for	IN	B-PP	O
VT	VT	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
simply	simply	RB	B-ADVP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Imdur	Imdur	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
hydrated	hydrate	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
G-tube	G-tube	NNP	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
sufficient	sufficient	JJ	B-NP	O
feeds	feed	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
issues	issue	NNS	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Nausea	Nausea	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Zofran	Zofran	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
good	good	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Urinary	Urinary	NNP	B-NP	O
Tract	Tract	NNP	I-NP	O
Infection	Infection	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
25	25	CD	I-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
increasing	increase	VBG	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
urination	urination	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
burning	burning	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
UA	UA	NNP	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
enterobacter	enterobacter	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
levo-sensitive	levo-sensitive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
prior	prior	JJ	B-ADJP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Synthroid	Synthroid	NN	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dosages	dosage	NNS	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in-house	in-house	JJ	B-ADJP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

GERD	GERD	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Prevacid	Prevacid	NN	B-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in-house	in-house	JJ	B-ADJP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

A-fib	A-fib	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
EGD	EGD	NN	I-NP	B-protein
and	and	CC	I-NP	O
G-tube	G-tube	JJ	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
either	either	CC	O	O
Lovenox	Lovenox	NN	B-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

or	or	CC	O	O
heparin	heparin	NN	B-NP	O
IV	IV	CD	I-NP	O
drip	drip	NN	I-NP	O
titrated	titrate	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
always	always	RB	B-ADVP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
anticoagulin	anticoagulin	NN	I-NP	B-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
any	any	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
her	her	PRP$	B-NP	O
goal	goal	NN	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
multivitamin	multivitamin	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
or	or	CC	I-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Prevacid	Prevacid	NN	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
Code	Code	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

COMMUNICATION	COMMUNICATION	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
much	much	JJ	B-NP	O
communication	communication	NN	I-NP	O
between	between	IN	B-PP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
wishes	wish	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
agreed	agree	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
rehab	rehab	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
place	place	NN	I-NP	O
for	for	IN	B-SBAR	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-5879021	0-5879021	CD	B-NP	O
HFFocus	HFFocus	NN	I-NP	O
transcriptionists	transcriptionist	NNS	I-NP	O
Dictated	Dictate	VBD	B-VP	O
By	By	NNP	B-NP	O
:	:	:	O	O
CRAFTON	CRAFTON	NNP	B-NP	O
,	,	,	O	O
BENEDICT	BENEDICT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KONDERLA	KONDERLA	NNP	B-NP	O
,	,	,	O	O
KIRK	KIRK	NNP	B-NP	O
TANNER	TANNER	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3468577	3468577	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/7/05	11/7/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/7/05	11/7/05	CD	B-NP	O

